Microsphere preparation for naproxen slow release was investigated usi
ng two newly prepared biodegradable polyorganophosphazenes, derivatize
d at the phosphorus atoms with phenylalanine ethyl ester and imidazole
at molar ratios of 71/29 and 80/20. The polymers were prepared by sub
stitution of the chloride atoms of polydichlorophosphazene with a phen
ylalanine ethyl ester-imidazole mixture followed, after 7 or 48 h reac
tion, by the addition of excess imidazole. Three methods of microspher
e preparation have been considered: spray-drying, emulsion/solvent eva
poration and emulsion/solvent evaporation-extraction. Microparticles o
btained by spray-drying were found to possess a narrow distribution si
ze with a mean diameter of 2-5 mu m. Their internal structure consiste
d of a porous or empty core depending upon the solvent used for the pr
eparation. Furthermore the microspheres prepared with this technique r
apidly released the entrapped naproxen independently of the used polym
er, the drug loading or the preparation process. On the other hand mic
rospheres prepared by solvent evaporation or solvent evaporation-extra
ction showed a distribution size ranging between 10 and 100 mu m. By t
he appropriate choice of pH and solvent composition of the external ph
ase, naproxen could be entrapped, in these microspheres, with a yield
higher of 80%. The polymer composition dictates the in vitro release r
ate of naproxen from the particles, which was faster when the microsph
eres were prepared with the polymer at higher imidazole content. In vi
vo experiments, carried out by subcutaneous implantation in rats of mi
crospheres prepared by solvent evaporation, demonstrated that a consta
nt level of naproxen in plasma could be maintained up to 400 h at a su
itable concentration for antinflammatory activity. (C) 1998 Elsevier S
cience B.V.